Claudia Lengerke
Universität Basel
H-index: 43
Europe-Switzerland
Top articles of Claudia Lengerke
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Real-world evidence on tagraxofusp for blastic plasmacytoid dendritic cell neoplasm–collected cases from a single center and case reports | Frontiers in Oncology | Philipp Faustmann Jan C Schroeder Lucas Mix Lennart Harland Andreas Riedel | 2024 |
Treatment response of advanced HNSCC towards immune checkpoint inhibition is associated with an activated effector memory T cell phenotype | Frontiers in Oncology | Max Schumacher Sina Beer Emmanuelle Moraes Ribeiro Fulya Korkmaz Hildegard Keppeler | 2024/3/7 |
Allogeneic CD19/CD22 CAR T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia | JAMA oncology | Laurent Phely Luca Hensen Christoph Faul Christer Alexander Ruff Dina Schneider | 2024/4/18 |
Laminin Receptor Characterization in Acute Myeloid Leukemia: Integrin α7β1 Defines non-Leukemic Stem Cells with Migratory Potential | bioRxiv | Elsa Goersch Marlon Arnone Maksim Klimiankou Jan Weller Saskia Rudat | 2024 |
Allogeneic hematopoietic stem cell transplantation in patients aged 60-79 years in Germany (1998-2018): a registry study | Acta Haematologica | Thomas Weber Sunday Ocheni Mascha Binder Sebastian Theurich Christof Scheid | 2013/4/1 |
CRISPR/Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia | Molecular Therapy | Masoud Nasri Malte Ritter Perihan Mir Benjamin Dannenmann Masako M Kaufmann | 2024/3/30 |
PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivity | Journal for Immunotherapy of Cancer | Emmanuelle Moraes Ribeiro Kathy-Ann Secker Ana-Maria Nitulescu Rebekka Schairer Hildegard Keppeler | 2024 |
Influence of ATLG Serum Levels on CD3/CD19-depleted Hematopoietic Grafts and on Immune Recovery in Pediatric Haplo-HSCT | Blood Advances | Claus-Philipp Maier Chihab Klose Christian Martin Seitz Florian Heubach Michaela Döring | 2024/1/30 |
Allogeneic hematopoietic cell transplantation for adult metachromatic leukodystrophy: a case series | Leukemia & Lymphoma | Sun-Hye Ko Jung-Hee Lee Je-Hwan Lee Han-Seung Park Eun-Ji Choi | 2018/8/3 |
Ulcerating skin lesions from blastic plasmacytoid dendritic cell neoplasm responding to low-dose radiotherapy—a case report and literature review | Strahlentherapie und Onkologie | Elgin Hoffmann Simon Böke Chiara De-Colle Claudia Lengerke Karim-Maximilian Niyazi | 2024/1/29 |
Redefining SOX2 as a bifunctional mediator of transcription and adjusted translation control | Cancer Research | Nitish Mittal Meric Ataman Hui Wang Silvia Candido Jonas Lötscher | 2024/3/22 |
The RORɣ/SREBP2 pathway is a master regulator of cholesterol metabolism and serves as potential therapeutic target in t(4;11) leukemia | Oncogene | Estelle Erkner Thomas Hentrich Rebekka Schairer Rahel Fitzel Kathy-Ann Secker-Grob | 2024/1/19 |
Patients with systemic sclerosis and low CD4 numbers after autologous stem cell transplantation have a favorable outcome | Arthritis Research & Therapy | Ann-Christin Pecher Reinhild Klein Ina Koetter Marieke Wagner Wichard Vogel | 2024/3/20 |
P462: RECIPIENT SEX AND DONOR RISK GROUP INFLUENCE LEUKEMIA KINETICS IN NSG MICE | HemaSphere | Marlon Arnone Anna Stanger Pauline Hanns Jessica Kuebler Elsa Goersch | 2023/8/1 |
CD19-targeting CAR T cells for myositis and interstitial lung disease associated with antisynthetase syndrome | Jama | Ann-Christin Pecher Luca Hensen Reinhild Klein Rebekka Schairer Katrin Lutz | 2023/6/27 |
Clinical outcome of biomarker-guided therapies in adult patients with tumors of the nervous system | Neuro-Oncology Advances | Mirjam Renovanz Sylvia C Kurz Johannes Rieger Bianca Walter Hannes Becker | 2023/1/1 |
Rational Combinatorial Targeting by Adapter CAR T Cells (AdCAR-T) Prevents Antigen Escape in Acute Myeloid Leukemia (AML) | Blood | Daniel Atar Lara Ruoff Anna-Sophia Mast Simon Krost Moustafa Moustafa-Oglou | 2023/11/28 |
iPSC modeling of stage-specific leukemogenesis reveals BAALC as a key oncogene in severe congenital neutropenia | Cell Stem Cell | Benjamin Dannenmann Maksim Klimiankou Benedikt Oswald Anna Solovyeva Jehan Mardan | 2023/9/7 |
Tuning of granulopoietic signaling byde novodesigned agonists | Timo Ullrich Christoph Pollmann Malte Ritter Jeremy Haaf Narges Aghaallaei | 2023/11/25 | |
RNA Therapeutics for Improving CAR T-cell Safety and Efficacy | Philipp Schaible Wolfgang Bethge Claudia Lengerke Reka Agnes Haraszti | 2023/2/3 |
